Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis.

Alessandro Rizzo Veronica MollicaMatteo SantoniGennaro PalmiottiFrancesco Massari

Published in: Journal of clinical medicine (2022)

Positive signals emanating from neoadjuvant immunotherapy should encourage the scientific community to persist in the long road toward finding more effective treatments for UC patients.

Keyphrases

locally advanced
rectal cancer
lymph node
end stage renal disease
ejection fraction
newly diagnosed
neoadjuvant chemotherapy
healthcare
mental health
prognostic factors
squamous cell carcinoma
radiation therapy
patient reported outcomes